Control of aspirin effect in chronic cardiovascular patients using two whole blood platelet function assays: PFA-100 and multiple electrode aggregometry

36th Hemophilia Symposium Hamburg 2005

Volumn , Issue , 2007, Pages 243-251

  Von Pape, K W ^a   Dzijan Horn, M ^c   Bohner, J ^c   Spannagl, M ^b   Weisser, H ^c   Calatzis, A ^b  

^a KLINIKUM FULDA   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c Hämostaseologie und Transfusionsmedizin ^*

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80053628244     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-36715-4_49     Document Type: Chapter

References (10)

1. Antithrombotic Trialists Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002; 324:71-86.
2. Kratzer MA, Born GV. Simulation of primary haemostasis in vitro. Haemostasis. 1985;15(6):357-62.
3. Calatzis A, Wittwer M, Krueger B. A new approach to platelet function analysis in whole blood - The Multiplate Analyzer. Platelets. 2004;15:479-517.
4. Cardinal DC, Flower RJ. The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods. 1980;3:135-158.
5. Grotemeyer KM. Effects of acetylsalicylic acid in stroke patients. Evidence of nonresponders in a subpopulation of treated patients. Thromb Res. 1991; 63:587-593
6. Pappas JM, Westengard JC, Bull BS. Population variability in the effect of aspirin on platelet function. Implications for clinical trials and therapy. Arch Pathol Lab Med. 1994; 118:801-804.
7. Gum PA, Kottke-Marchant K, Poggio ED et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol. 2001; 88: 230-235.
8. K.-W. von Pape, G. Strupp, T. Bonzel, J. Bohner Effect of compliance and dosage adaption of long term aspirin on platelet function with PFA-100 in patients after myocardial infarction. Thrombosis and Haemostasis 2005; 94: 889-891.
9. K.H. Grotemeyer, H.W. Scharafinski and I.W. Husstedt, Two-year-follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients. Thromb Res 71 (1993), pp. 397-403.
10. Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol EJ.A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. JACC. 2003; 41: 961-965.